NASDAQ Stock Exchange News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 928,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "a3bb351f-87e6-4bb4-9eab-c4f2b11cd81a",
"title": "Erasca Inc (ERAS) Aligns with EPS Projections, Reveals Robust Balance Sheet and Key Clinical Milestones",
"description": "Estimated Earnings Per Share (EPS): Erasca Inc reported an EPS of -$(0.20) for Q4 and -$(0.83) for the full year, aligning with analyst projections of -$0.2228",
"keywords": "GuruFocus, Article, News, GuruFocus Research, ERAS",
"snippet": "On March 27, 2024, Erasca Inc (ERAS, Financial) released its 8-K filing, providing a comprehensive overview of its fourth quarter and full year 2023 financial r...",
"url": "https://www.gurufocus.com/news/2401012/erasca-inc-eras-aligns-with-eps-projections-reveals-robust-balance-sheet-and-key-clinical-milestones",
"image_url": "https://static.gurufocus.com/logos/0C0000C72R.png?5",
"language": "en",
"published_at": "2024-03-29T09:31:31.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "ERAS",
"name": "Erasca, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 113.34732,
"sentiment_score": 0.358527,
"highlights": [
{
"highlight": "On March 27, 2024, <em>Erasca</em> <em>Inc</em> (<em>ERAS</em>, Financial) released its 8-K filing, providing a comprehensive overview of its fourth quarter and full year 2023 financial results, as well as significant business updates.",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "Company Overview\n\n<em>Erasca</em> <em>Inc</em> is at the forefront of precision oncology, with a clear focus on developing therapies for patients with RAS/MAPK pathway-driven cancers.",
"sentiment": 0.3818,
"highlighted_in": "main_text"
},
{
"highlight": "The company's promising pipeline includes naporafenib, a potential first-in-class pan-RAF inhibitor, and other candidates like <em>ERAS</em>-007 and <em>ERAS</em>-601, targeting different nodes of the RAS/MAPK pathway.",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Performance and Clinical Achievements\n\nDespite not generating revenue, which is typical for a clinical-stage biotechnology company, <em>Erasca</em> <em>Inc</em> has reported a solid cash position with $322 million in reserves. This financial stability is crucial for sustaining its research and development efforts.",
"sentiment": 0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "From a clinical perspective, <em>Erasca</em> <em>Inc</em> has reached significant milestones, including the Fast Track Designation for naporafenib in combination with trametinib for the treatment of melanoma.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "In 2023, our three clinical candidates reached important clinical and regulatory milestones, including gaining regulatory clarity to allow us to begin our global Phase 3 study for naporafenib, demonstrating encouraging therapeutic potential for <em>ERAS</em>-007, and achieving Fast Track Designation for each of naporafenib in combination with trametinib, and",
"sentiment": 0.9001,
"highlighted_in": "main_text"
},
{
"highlight": "<em>ERAS</em>-801,\" said Jonathan E.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Upcoming Milestones and Outlook\n\nLooking ahead, <em>Erasca</em> <em>Inc</em> anticipates multiple data readouts in 2024 for its leading candidates. The company's strong cash position is expected to support these efforts, providing the necessary resources to reach critical development milestones and potentially bring new cancer therapies to market.",
"sentiment": -0.1531,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Erasca</em> <em>Inc</em> will hold a conference call and webcast to discuss these results and updates in greater detail, offering an opportunity for investors and analysts to gain further insights into the company's strategies and expectations for the coming year.",
"sentiment": 0.8271,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings release (here) from <em>Erasca</em> <em>Inc</em> for further details.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Erasca</em> <em>Inc</em> (<em>ERAS</em>) Aligns with EPS Projections, Reveals Robust Balance Sheet and Key Clinical Milestones",
"sentiment": 0.34,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "f0861ae4-f684-4ac3-ba74-08346e1decab",
"title": "Vital Farms: Further Upside Is On The Table (NASDAQ:VITL)",
"description": "Premium egg producer Vital Farms sees 113.5% surge in stock price due to strong revenue growth, but it seems that more upside still exists.",
"keywords": "",
"snippet": "Thai Liang Lim/E+ via Getty Images\n\nAs a general rule of thumb, it is foolish to expect a stock to double or more than double in a short window of time. Althoug...",
"url": "https://seekingalpha.com/article/4681208-vital-farms-further-upside-is-on-the-table",
"image_url": "https://media.gettyimages.com/id/1590966601/photo/a-cropped-image-of-a-womans-hand-holding-a-piece-of-toasted-bread-with-scrambled-eggs-on-top.jpg?b=1&s=170667a&w=0&k=20&c=Q1FbScUpfW09zHMU5IQeMJ8ATIyXaXvIba19dp4ZG5A=",
"language": "en",
"published_at": "2024-03-29T09:10:02.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "VITL",
"name": "Vital Farms, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 108.80488,
"sentiment_score": 0.475533,
"highlights": [
{
"highlight": "But one firm that has experienced this kind of move higher that likely does warrant a little additional upside is premium egg producer <em>Vital</em> <em>Farms</em> (<em>NASDAQ:VITL</em>).\n\nBack in October of 2023, I ended up upgrading the company from a 'hold' to a 'buy'. Up to that point, I had been rather neutral on the business.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "While the S&P 500 is up 26.1% since then, shares of <em>Vital</em> <em>Farms</em> have seen upside of 113.5%. Clearly, the easy money has been made. But I would argue that some additional upside probably exists from here. So because of that, I have decided to keep the company rated a soft 'buy' at this time.",
"sentiment": 0.6597,
"highlighted_in": "main_text"
},
{
"highlight": "The picture keeps improving\n\nFundamentally speaking, things are going quite well for <em>Vital</em> <em>Farms</em> and its investors. Take the final quarter of the 2023 fiscal year as an example. During that time, revenue for the business came in at $135.8 million. That's 23.3% higher than the $110.1 million reported one year earlier.",
"sentiment": 0.6326,
"highlighted_in": "main_text"
},
{
"highlight": "Author - SEC EDGAR Data\n\nOn the bottom line, <em>Vital</em> <em>Farms</em> performed really well. Net income spiked from $1.9 million to $7.2 million. And operating cash flow improved from negative $4.7 million to positive $23.7 million. If we adjust for changes in working capital, we get exactly a doubling in the metric from $6.8 million to $13.6 million.",
"sentiment": 0.6557,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Vital</em> <em>Farms</em>\n\nThe really exciting thing for shareholders is that management expects growth for the enterprise to continue. For starters, according to management, several states, including California, Massachusetts, Oregon, and others, have all passed legislation to remove caged eggs from their markets.",
"sentiment": 0.7239,
"highlighted_in": "main_text"
},
{
"highlight": "This will increase the demand for the cage free eggs promoted by <em>Vital</em> <em>Farms</em>. In fact, the company boasts that the average hen has an open air, 108 square foot space. In addition to becoming more popular because of regulatory changes, consumers are snatching up its eggs.",
"sentiment": 0.8739,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Vital</em> <em>Farms</em>\n\nManagement believes that continued investment, including between $35 million and $45 million on capital expenditures this year, that will help it grow capacity to the point where revenue should be $1 billion or higher by 2027. Of course, the company has to get there one step at a time.",
"sentiment": 0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "Company Price / Operating Cash Flow EV / EBITDA <em>Vital</em> <em>Farms</em> 19.8 17.7 SunOpta (STKL) 51.6 25.3 The Hain Celestial Group (HAIN) 6.9 16.1 B&G Foods (BGS) 3.4 16.7 Mission Produce (AVO) 20.8 15.1 Adecoagro (AGRO) 2.4 3.0 Click to enlarge\n\nTakeaway\n\nFundamentally speaking, <em>Vital</em> <em>Farms</em> is doing really well for itself.",
"sentiment": 0.3321,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Vital</em> <em>Farms</em>: Further Upside Is On The Table (<em>NASDAQ:VITL</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "5b4d95e0-62e1-4042-b084-ae9cde010cec",
"title": "Management’s Conservative Guidance Led Legend Biotech Corporation (LEGN) to Decline in Q4",
"description": "TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here.",
"keywords": "",
"snippet": "Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!\n\nThe ...",
"url": "https://www.insidermonkey.com/blog/managements-conservative-guidance-led-legend-biotech-corporation-legn-to-decline-in-q4-1282480/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/12/16124710/ADIL-insidermonkey-1702748828493.jpg",
"language": "en",
"published_at": "2024-03-29T09:09:47.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "LEGN",
"name": "Legend Biotech Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 125.37077,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Management’s Conservative Guidance Led <em>Legend</em> <em>Biotech</em> <em>Corporation</em> (LEGN) to Decline in Q4",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "98ea25b0-9185-46d2-8bbc-e0efb88e9b98",
"title": "Global Coffee Concentrates Market Size To Worth USD 4.45 Billion By 2033 | CAGR of 5.20%",
"description": "The Global Coffee Concentrates Market Size was Valued at USD 2.68 Billion in 2023 and the Worldwide Coffee Concentrates Market Size is Expected to Reach...",
"keywords": "SPHERICAL INSIGHTS LLP, Coffee Concentrates Market, Concentrates Market Size, Concentrates Market Share, Concentrates Market Analysis, Growth, Trends, Price",
"snippet": "New York, United States , March 29, 2024 (GLOBE NEWSWIRE) -- The Global Coffee Concentrates Market Size is to Grow from USD 2.68 Billion in 2023 to USD 4.45 Bil...",
"url": "https://www.globenewswire.com/news-release/2024/03/29/2854641/0/en/Global-Coffee-Concentrates-Market-Size-To-Worth-USD-4-45-Billion-By-2033-CAGR-of-5-20.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/b27a94e8-407e-46ae-a5c2-47bb2a1c8a2e",
"language": "en",
"published_at": "2024-03-29T09:00:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "SBUX",
"name": "Starbucks Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 10.915258,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Major vendors in the global coffee concentrates market include Javy Coffee Company, <em>Starbucks</em> <em>Corporation</em>, Ueshima Coffee Co. Ltd., Nestle S.A., Climpson & Sons, Monin, Kohansa Coffee, PepsiCo, Inc., The J.M.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PEP",
"name": "PepsiCo, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 11.186922,
"sentiment_score": 0,
"highlights": [
{
"highlight": "., Climpson & Sons, Monin, Kohansa Coffee, <em>PepsiCo</em>, <em>Inc</em>., The J.M. Smucker Company, Kraft Foods Group, Blue Bottle Coffee, Inc., S&D Coffee Inc., Aspen Beverage Group, LLC., Grady’s Cold Brew, Wandering Bear Coffee, Others.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "23d7c0cf-67b6-4078-a8c8-93ae03959668",
"title": "Bilibili Inc. Announces Completion of the Repurchase Right Offer for 1.375% Convertible Senior Notes due 2026",
"description": "SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) -- Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI and HKEX: 9626), an iconic brand and a...",
"keywords": "Nasdaq:BILI, Bilibili Inc.",
"snippet": "SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) -- Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI and HKEX: 9626), an iconic brand and a lea...",
"url": "https://www.globenewswire.com/news-release/2024/03/29/2854643/0/en/Bilibili-Inc-Announces-Completion-of-the-Repurchase-Right-Offer-for-1-375-Convertible-Senior-Notes-due-2026.html",
"image_url": "https://www.globenewswire.com/Content/logo/favicon.ico",
"language": "en",
"published_at": "2024-03-29T09:00:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "BILI",
"name": "Bilibili Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 91.453354,
"sentiment_score": 0.230638,
"highlights": [
{
"highlight": "SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) -- <em>Bilibili</em> <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(“<em>Bilibili</em>” or the “Company”) (<em>NASDAQ</em>: <em>BILI</em> and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced that it has completed its previously announced repurchase right offer relating to its 1.375% Convertible Senior Notes due 2026 (CUSIP No. 090040AB2) (the “Notes”).",
"sentiment": -0.296,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Bilibili</em> <em>Inc</em>.\n\n<em>Bilibili</em> is an iconic brand and a leading video community with a mission to enrich the everyday lives of young generations in China. <em>Bilibili</em> offers a wide array of video-based content with All the Videos You Like as its value proposition.",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Bilibili</em> builds its community around aspiring users, high-quality content, talented content creators and the strong emotional bonds among them.",
"sentiment": 0.802,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Bilibili</em> pioneered the “bullet chatting” feature, a live comment function that has transformed our users’ viewing experience by displaying the thoughts and feelings of audience members viewing the same video.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "For investor and media inquiries, please contact:\n\nIn China:\n\n<em>Bilibili</em> <em>Inc</em>.",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "Juliet Yang\n\nTel: +86-21-2509-9255 Ext. 8523\n\nE-mail: [email protected]\n\nPiacente Financial Communications\n\nHelen Wu\n\nTel: +86-10-6508-0677\n\nE-mail: <em>bilibili</em>@tpg-ir.com\n\nIn the United States:\n\nPiacente Financial Communications\n\nBrandi Piacente\n\nTel: +1-212-481-2050\n\nE-mail: <em>bilibili</em>@tpg-ir.com",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Bilibili</em> <em>Inc</em>. Announces Completion of the Repurchase Right Offer for 1.375% Convertible Senior Notes due 2026",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "20d94cfb-836e-41b6-8f88-f47771bd1c09",
"title": "PKSHA、日本マイクロソフト支援のもと大規模言語モデルを開発",
"description": "",
"keywords": "AI",
"snippet": "PKSHA Technologyは、Retentive Network(RetNet)(※1)を活用した日英大規模言語モデル(Large Language Model、以下LLM)を開発する?...",
"url": "https://saleszine.jp/news/detail/5726",
"image_url": "https://saleszine.jp/static/images/article/5726/5726_01.png",
"language": "ja",
"published_at": "2024-03-29T09:00:00.000000Z",
"source": "saleszine.jp",
"relevance_score": null,
"entities": [
{
"symbol": "MSFT",
"name": "Microsoft Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 13.80673,
"sentiment_score": null,
"highlights": [
{
"highlight": "RetNetは、マイクロソフトの研究開発機関である<em>Microsoft</em> Researchによって開発され、学習速度、長文入力時の推論速度やメモリ効率が優れているうえに、従来と同等以上の精度を持つことが示されている。メモリ効率に優れるということは、従来モデルよりも少ないGPU(※2)で運用することができ、コスト面でも優れている。このアーキテクチャを使用することで効率的な長文理解と、優れた回答速度を両立する日英対応のLLMの実現を図る。\n\nモデルのパラメータ数としては、コンタクトセンターなどにおける実装を視野に、出力精度と運用コストのバランスに優れた70億パラメータを採用。",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "また、モデルの開発には<em>Microsoft</em> <em>Corporation</em>によって研究開発された深層学習フレームワーク「DeepSpeed」を採用し、その強みである高い並列分散処理能力を発揮するためのLLM学習ノウハウとAzure上のGPUサーバー群が日本マイクロソフトから提供されている。DeepSpeedの活用により効率的に学習を進め、プロトタイプモデルによる性能確認を早期に実現した。",
"sentiment": 0.0258,
"highlighted_in": "main_text"
},
{
"highlight": "この革新的なプロジェクトは、<em>Microsoft</em> Research 開発の先進技術「RetNet」及び <em>Microsoft</em> <em>Corporation</em>にて開発された「DeepSpeed」を活用した日英対応の言語モデルであり、従来のモデルより3倍の速度で回答を生成することが可能です。これにより、コンタクトセンターや社内ヘルプデスクの生産性向上が期待できます。株式会社PKSHA Technology様のこの取り組みは、コミュニケーションの即時性と精度を高めることで、企業の効率化とサービス品質の向上を支援しております。\n\n日本マイクロソフトは、PKSHA Technology様の「人とソフトウェアの共進化」のビジョンと、その実現に向けた革新的な取り組みを全力でサポートしてまいります。",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "1e9fad3f-e604-49bc-a98d-747bc4de212f",
"title": "Apple, Huawei likely to aid rebound in smartphone shipments in 2024: Counterpoint",
"description": "The smartphone market is expected to rebound in 2024, rising 3% year-over-year and hitting 1.2B units, led by a rebound in the budget and premium segments. Read for more.",
"keywords": "",
"snippet": "The smartphone market is expected to rebound in 2024, rising 3% year-over-year and hitting 1.2B units, led by a rebound in both the budget and premium segments,...",
"url": "https://seekingalpha.com/news/4084883-apple-huawei-likely-aid-rebound-smartphone-shipments-2024-counterpoint",
"image_url": "https://media.gettyimages.com/id/1722058098/photo/apple-iphone-15-pro.jpg?b=1&s=170667a&w=0&k=20&c=o1DQ-rWVoSZESNdEF9CeXoRs7zBp5ivfGg3YxyNABSY=",
"language": "en",
"published_at": "2024-03-29T09:00:00.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "AAPL",
"name": "Apple Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 28.169304,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Apple</em> (<em>NASDAQ:AAPL</em>) and Huawei are expected to aid the premium segment of the market, defined as phones priced between $600 and $799, which is expected to grow 17% year-over-year, Counterpoint said in a statement.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em> is slated to host its annual developers conference in June, where it is widely expected to unveil several AI-related updates to its iOS mobile operating system.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Apple</em>, Huawei likely to aid rebound in smartphone shipments in 2024: Counterpoint",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "9dd8a930-f40c-4603-8f1f-22014cab561a",
"title": "Axcelis Technologies Stock: Beware Of The Potential Value Trap (NASDAQ:ACLS)",
"description": "Axcelis has doubled its revenues with the growth of power semiconductors, but recent trends indicate near-term weakness. Click here to read my analysis.",
"keywords": "",
"snippet": "PonyWang\n\nMy thesis\n\nAxcelis Technologies (NASDAQ:ACLS) has outpaced every expectation since 2019, nearly tripling its revenues. Strong growth from China and th...",
"url": "https://seekingalpha.com/article/4681202-axcelis-technologies-beware-of-the-potential-value-trap",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1363604154/image_1363604154.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-29T08:44:59.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "ACLS",
"name": "Axcelis Technologies, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 105.1759,
"sentiment_score": 0.317267,
"highlights": [
{
"highlight": "PonyWang\n\nMy thesis\n\n<em>Axcelis</em> <em>Technologies</em> (<em>NASDAQ:ACLS</em>) has outpaced every expectation since 2019, nearly tripling its revenues. Strong growth from China and the power semiconductor end market has played an important role in such success. The firm managed to outperform TAM expectations while staying competitive against Applied Materials (AMAT).",
"sentiment": 0.926,
"highlighted_in": "main_text"
},
{
"highlight": "Investment overview\n\n<em>Axcelis</em> <em>Technologies</em> is a US-based semiconductor company founded in 1995. It designs and manufactures its ion implanter machines in Beverly, Massachusetts, and has recently opened a facility in South Korea. In FY2023, the firm generated revenues of $1.1bn for an EBITDA of $280m and an FCF of $130m.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Axcelis</em> <em>Technologies</em> Stock: Beware Of The Potential Value Trap (<em>NASDAQ:ACLS</em>)",
"sentiment": 0.0258,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "d7d3a462-6227-4bd3-bb90-fad4282c6c82",
"title": "Here’s Why argenx SE (ARGX) Pulled Back 23% in Q4",
"description": "TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here.",
"keywords": "",
"snippet": "Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!\n\nThe ...",
"url": "https://www.insidermonkey.com/blog/heres-why-argenx-se-argx-pulled-back-23-in-q4-1282488/",
"image_url": "https://d2gr5kl7dt2z3t.cloudfront.net/blog/wp-content/uploads/2023/12/15151014/JAGX-insidermonkey-1702671012730.jpg",
"language": "en",
"published_at": "2024-03-29T08:42:25.000000Z",
"source": "insidermonkey.com",
"relevance_score": null,
"entities": [
{
"symbol": "ARGX",
"name": "argenx SE",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 104.139244,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Here’s Why <em>argenx</em> <em>SE</em> (ARGX) Pulled Back 23% in Q4",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "879e9264-64a9-4db4-862a-5baad58abfd7",
"title": "Nvidia, Amazon And Microsoft's Recent Activity Indicate Impending AI Bubble: 'When The Music Stops There Will Not Be Many Chairs Available' - Microsoft (NASDAQ:MSFT), Amazon.com (NASDAQ:AMZN)",
"description": "The first is the reported $5 billion valuation of NVIDIA (NASDAQ: NVDA) -backed generative AI company Cohere, which almost doubled its value last June, despite a 2023 annual revenue of just $13 million. Windsor called this a",
"keywords": "",
"snippet": "Loading... Loading...\n\nThe ongoing excitement surrounding AI has prompted an analyst to highlight potential indicators of an impending market correction. Richar...",
"url": "https://www.benzinga.com/analyst-ratings/analyst-color/24/03/38001796/nvidia-amazon-and-microsofts-recent-activity-indicate-impending-ai-bubble-when-the-",
"image_url": "https://cdn.benzinga.com/files/images/story/2024/Kaufbeuren--Germany---April-26--2021-Nvi_5.jpeg?width=1200&height=800&fit=crop",
"language": "en",
"published_at": "2024-03-29T08:39:48.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "AMZN",
"name": "Amazon.com, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 41.235962,
"sentiment_score": 0.0258,
"highlights": [
{
"highlight": "Nvidia, Amazon And Microsoft's Recent Activity Indicate Impending AI Bubble: 'When The Music Stops There Will Not Be Many Chairs Available' - Microsoft (NASDAQ:MSFT), <em>Amazon.com</em> (<em>NASDAQ:AMZN</em>)",
"sentiment": 0.0258,
"highlighted_in": "title"
}
]
},
{
"symbol": "MSFT",
"name": "Microsoft Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 34.643578,
"sentiment_score": 0.1314,
"highlights": [
{
"highlight": "The “unusual deal” allegedly involves <em>Microsoft</em> paying around $650 million in cash to hire Inflection AI’s staff and use its technology.\n\nThe third concern is Amazon’s AMZN additional $2.75 billion investment in Anthropic, a generative AI startup. Windsor highlighted the “FOMO effect” around AI, noting that even tech giants are not immune to it.",
"sentiment": -0.0904,
"highlighted_in": "main_text"
},
{
"highlight": "Just a day before Windsor’s note, it was reported that <em>Microsoft</em> was the most-purchased AI stock by Congress, surpassing Nvidia. This indicates the widespread interest in AI and the potential impact of major players in the sector.",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Nvidia, Amazon And Microsoft's Recent Activity Indicate Impending AI Bubble: 'When The Music Stops There Will Not Be Many Chairs Available' - <em>Microsoft</em> (<em>NASDAQ:MSFT</em>), Amazon.com (NASDAQ:AMZN)",
"sentiment": 0.0258,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "NASDAQ",
"total_documents": 1547,
"sentiment_avg": 0.28025815438038276
}
]
}
Other details
Country
- us
- 5,275